NCT06926803 2025-04-15
A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal Metastases
Henan Cancer Hospital
Active not recruiting
Henan Cancer Hospital
Instituto Nacional de Cancerologia, Columbia
Azienda USL Reggio Emilia - IRCCS
National Cancer Center, Korea